Tech & industry
Rehab technology, assistive tech, equipment and the companies behind them.

Human-centred AI: What neurorehabilitation stands to gain and guard against
By Rachel Maxwell, social media and marketing officer, BIS Services [...]
- Tech & industry29 Oct
By Rachel Maxwell, social media and marketing officer, BIS Services "Bad people move fast. Good people must too." This line, delivered by AI and systems expert Rebecca Whitney at BIS Services' Human-Centred AI conference last month, landed hard in a room full neurorehabilitation professionals who have spent careers being deliberately, carefully slow. In neurorehabilitation, caution [...]
- Tech & industry28 Oct
Finding the right transport solution for your client is an important role for any Occupational Therapist or Case Manager. Brotherwood can help you guide your clients through the available options, to make the right choice for their needs and ensure a successful outcome. How can Brotherwood help: When assessing the most suitable transport for a [...]
- Brain injury26 Oct
By The Children’s Trust Every year, 40,000 children in the UK experience a brain injury. Around 350 sustain a severe acquired brain injury requiring rehabilitation, but only a fraction can access the specialist treatment provided by The Children's Trust. For those who do, the impact can be life-changing. At the national specialist centre in Tadworth, [...]
- Brain injury23 Oct
Patients who appear to be in a coma may be able to communicate through their thoughts, according to new research into severe brain injury. A brain-computer interface allowed about one in three unresponsive patients with acute brain injury to control a beeping tone using their thoughts. The non-invasive technology uses electrodes placed on the scalp [...]
- MND / ALS21 Oct
Clene Nanomedicine has applied for accelerated FDA approval of CNM-Au8, an experimental oral treatment for amyotrophic lateral sclerosis (ALS). The company submitted its new drug application earlier this month, supported mainly by clinical data suggesting the therapy can reduce blood levels of neurofilament light chain (NfL), a marker of nerve damage. Further analyses have linked [...]
- Spinal injury16 Oct
Seven people with chronic paraplegia used a ReWalk exoskeleton at home for up to 45 months, reporting improvements in quality of life and no falls or device-related fractures. The independent study examined long-term use of the wearable robotic device, which enables people with spinal cord injuries to stand, walk and navigate stairs and kerbs. Participants [...]
- Tech & industry14 Oct
A £45,000 award will fund MRI research aimed at improving the diagnosis and treatment of children with brain tumours. The project will examine how magnetic resonance imaging (MRI) could help clinicians identify likely tumour types and prognosis. A doctoral student will develop a computer model that learns from existing MRI scans and [...]
- Tech & industry7 Oct
Three researchers have won the Nobel Prize in Physiology or Medicine for work using light to control neural circuits. Karl Deisseroth, Peter Hegemann and Georg Nagel were recognised for research that allows scientists to switch specific neural circuits on and off. The technique has helped researchers study brain mechanisms involved in memories, feelings and behaviours, [...]
- Tech & industry24 Sep
A specialist Norfolk neurorehabilitation centre supporting adults with brain injuries and neurological conditions is set to close after demand declined. CareTech has begun the managed closure of the All Hallows Neuro-Rehabilitation Service in Ditchingham, near Bungay, saying falling demand has made the facility unsustainable. The provider said the decision was not related to the quality [...]
- Brain injury21 Sep
Researchers in Portugal are investigating a promising new treatment for traumatic brain injury (TBI) after discovering that the brain's two hemispheres respond differently to trauma. Initial findings also suggested the treatment helped protect the blood-brain barrier and reduce neuroinflammation. Researchers at the University of Coimbra are investigating neuropeptide Y, a molecule that occurs [...]
















